Rates and sensitivity of knee cartilage thickness loss in specific central reading radiographic strata from the osteoarthritis initiative  by Maschek, S. et al.
Osteoarthritis and Cartilage 22 (2014) 1550e1553Brief ReportRates and sensitivity of knee cartilage thickness loss in speciﬁc central
reading radiographic strata from the osteoarthritis initiative
S. Maschek y z, W. Wirth y z, C. Ladel x, M.-P. Hellio Le Graverand k, F. Eckstein y z *
y Institute of Anatomy, Paracelsus Medical University, Salzburg, Austria
z Chondrometrics GmbH, Ainring, Germany
x Merck KGaA, Darmstadt, Germany
k Pﬁzer Development Japan, Tokyo, Japana r t i c l e i n f o
Article history:
Received 31 January 2014






Sensitivity to change* Address correspondence and reprint requests
Anatomy, Paracelsus Medical University, Strubergasse
Tel: 43-662-44-2002-1240; Fax: 43-662-44-2002-124
E-mail address: felix.eckstein@pmu.ac.at (F. Eckste
http://dx.doi.org/10.1016/j.joca.2014.05.015
1063-4584/© 2014 Osteoarthritis Research Society Ins u m m a r y
Objective: To compare the rate and sensitivity to change of quantitative cartilage thickness change with
magnetic resonance imaging (MRI) across speciﬁc radiographic strata of knee osteoarthritis (KOA) from
central expert readings of the Osteoarthritis Initiative (OAI). Speciﬁcally, we explored whether Kellgren
Lawrence grade (KLG) 2 knees with radiographic joint space narrowing (JSN) displayed greater cartilage
loss than those without JSN, and whether knees with medial JSN grade2 had greater loss than those with
grade1.
Methods: One-year femorotibial cartilage thickness change was obtained for 836 knees, 112 without, and
724 with deﬁnite radiographic KOA based on baseline site readings. The maximum subregional cartilage
loss, and cartilage thickness change in the total femorotibial joint (FTJ) and medial femorotibial
compartment (MFTC) were analyzed across different radiographic strata (central vs site readings).
Results: The maximum subregional rate of change was signiﬁcantly greater in central_KLG2 knees with
than in those without JSN (172 ± 152 vs 134 ± 100 mm; P ¼ 0.03). In contrast, the rate did not differ
signiﬁcantly between central_KLG1 knees with and without JSN. MFTC cartilage loss in central_-
medial_grade2 JSN knees was substantially and signiﬁcantly greater than in grade1 knees (70 ± 159
vs 31 ± 126 mm; P ¼ 0.02). For comparison, the loss in grade3 knees was 72 ± 122 mm.
Conclusions: In KLG2 knees, presence of radiographic JSN was associated with signiﬁcantly and sub-
stantially greater rates of subregional cartilage loss. Differentiating knees with mild vs moderate medial
JSN, and deﬁnite radiographic OA knees with vs without JSN is important in predicting structural pro-
gression of KOA, and for planning clinical trials testing the efﬁcacy of disease modifying drugs (DMOADs).
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The Osteoarthritis Initiative (OAI) is an ongoing multi-center
study (http://www.oai.ucsf.edu) targeted at identifying sensitive
(imaging) biomarkers for onset and progression of knee osteoar-
thritis (KOA)1. 4674 participants with all grades of radiographic
knee osteoarthritis (RKOA) and 122 healthy participants without
symptoms, signs and risk factors of RKOA were studied annually
over 48 months and longer1, using ﬁxed ﬂexion radiography2 and
magnetic resonance imaging (MRI)1,3.to: F. Eckstein, Institute of
21, A5020 Salzburg, Austria.
9.
in).
ternational. Published by Elsevier LWe previously reported quantitative cartilage thickness loss in a
large subsample of the OAI and reported rates and sensitivity to
change across different radiographic strata (i.e., Kellgren Lawrence
grades [KLG])4. This analysis relied on the radiographic readings
from the four clinical OAI sites available then. Healthy reference and
KLG2 knees displayed minimal cartilage thickness loss; KLG3 and 4
knees displayed signiﬁcantly greater loss than KLG2 knees. Since,
central readings from experts at Boston University have been made
available1, and it has been found that central radiographic grading
may differ substantially from that at the clinical sites, because
different thresholds exist between readers for scoring osteophytes
and radiographic joint space narrowing (JSN)5. The central readings
used the traditional KLG classiﬁcation6 as well as Osteoarthritis
Research Society International (OARSI) osteophyte and JSN scores7
and applied the full spectrum of OARSI JSN grades1e37, whereas the
site readings had collapsed grades1e2 into a single grade.td. All rights reserved.
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sensitivity to change of quantitative cartilage thickness loss be-
tween speciﬁc RKOA strata of central OAI readings, and to list those
side-to-side with previously published site-reading strata4. Spe-
ciﬁcally, we tested whether knees classiﬁed centrally as KLG 2 (and
1) display greater cartilage loss with presence of JSN, and whether
medial JSN grade2 knees display greater medial cartilage loss than
JSN grade1 knees.
Methods
MRI acquisition and analysis
The OAI1, the subsample studied, its demographics, and the MRI
acquisition and image analysis technology have been described
previously4. Fixed ﬂexion radiographs were acquired using a Syn-
aﬂexer frame2, and 3T double oblique coronal FLASH MRIs (Online
Fig. 1) according to the OAI protocol (http://www.oai.ucsf.edu/)1,3.
The longitudinal analysis of femorotibial cartilage thickness change
in this subsample was funded by a consortium of industry partners,
the OAI coordinating center, and an image analysis company
(Chondrometrics GmbH). Segmentation of baseline and year-1
follow-up images (Online Fig. 1) was performed with blinding to
time-point4. The number of segmented slices of each cartilage plate
was matched between time points, but no prospective or retro-
spective registration was performed. To minimize differences be-
tween readers, all segmentations were quality controlled by one
expert (SM). The mean cartilage thickness (ThCtAB.Me) was
computed in the medial and lateral tibia and weight-bearing
femoral condyles4 (Online Fig. 1), and in 16 femorotibial sub-
regions8, for which the test-retest errors (RMS SD) have been re-
ported to range from 19 mm to 84 mm. Non-location dependent rates
of subregional cartilage loss were determined using an ordered
value (OV) approach4,9. In each knee, subregional rates of change
were ranked to determine OV1, i.e., the rate of cartilage thickness
loss (in mm) in the subregion with the greatest loss4,9. OV1 is a
location-independent measure and has been associated similarly
with medial or lateral JSN10.
Radiographic strata
The previous study relied on baseline KLGs assigned by centrally
trained and certiﬁed readers (one to three validated radiologists or
rheumatologist) at each of four clinical OAI sites4. KLGs were
“calculated” from OARSI atlas osteophyte and JSN grades7. Readers
assessed each knee for presence/absence of deﬁnite marginal
osteophytes (OARSI atlas grade1e3, any medial and lateral, tibial
and femoral osteophytes), and medial and lateral OAI JSN grades1
(OARSI atlas grades1e2) or 2 (OARSI atlas grade3). The siteKLG was
deﬁned as: 0 ¼ osteophytes and JSN scores ¼ 0; 1 ¼ questionable
osteophyte and OAI JSN grade0e1 (or grade0 osteophyte and OAI
JSN grade1); 2 ¼ deﬁnite osteophyte and OAI JSN grade0 (or no/
questionable osteophyte and OAI JSN grade2); 3 ¼ deﬁnite osteo-
phyte and OAI JSN grade1; 4 ¼ deﬁnite osteophyte and OAI JSN
grade2, OAI JSN grade1 corresponding to “deﬁnite mild” and not to
“possible or uncertain” JSN.
In the present analysis central radiographic readings (release
0.5) by three expert radiologists or rheumatologists at Boston
University were used (https://oai.epi-ucsf.org/datarelease/
SASDocs/kXR_SQ_BU_descrip.pdf). KLGs were assigned pertinent
to the original description6, independent of OARSI atlas osteophyte
and JSN grades (Online Fig. 1)7. Knees with presence of doubtful
osteophytes and possible JSN were graded KLG1 [Online Fig. 1(b)],
those with deﬁnite osteophytes and possible JSN KLG2 [Online
Fig. 1(c/d)], and those with presence of moderate multipleosteophytes, deﬁnite JSN, subchondral sclerosis, and (possible)
deformity of the bone KLG3 or 4 [Online Fig. 1(e)].
Study sample
Cartilage thickness measurements were available for 837 knees
from 837 participants (one knee from each). The selection criteria
were reported previously4. One knee that had been assigned KLG3
by the site had no central reading performed and was hence not
included in the current analysis. Our previous study4 reported re-
sults for 831 knees: 112 from the healthy reference sample, 310
sKLG2, 300 sKLG3, and 109 sKLG4. Six knees with JSN but without
deﬁnite osteophytes had not been included in the previous anal-
ysis4, but were included in the current study, because the central
readings did not conﬁrm the above ﬁndings.
Statistical analysis
The mean, standard deviation (SD) and 95% conﬁdent intervals
of change in cartilage thickness (ThCtAB; mm) between baseline and
year-1 follow-up was determined, and the standardized response
mean (SRM ¼ mean/SD change) was used as a measure of the
sensitivity to change. OV1 and femorotibial joint (FTJ) rates of
change were compared between KLG2 knees with and without JSN,
using an unpaired Student's t test. The same comparison was made
for KLG1 knees. The same procedure was used to test whether
medial OARSI JSN grade2 knees displayed greater cartilage loss than
grade1 knees. Analysis of variance (ANOVA) was then used to
conﬁrm whether the inferences would hold after accounting for
age, sex, and BMI. MFTC cartilage change was used here, because
medial JSN was associated with cartilage loss in the medial but not
in the lateral compartment10. No statistical comparisons were
made between site and central reading strata in order to avoid is-
sues of multiple parallel testing on readings with different
constructs.
Results
Of 836 study participants, the 112 from the healthy reference
cohort were [mean ± SD] 55 ± 7.7 years (BMI 24.3 ± 3.0), whereas
the 724 knees with RKOA (site readings) were 63 ± 9.3 years (BMI
29.6 ± 4.7). Of the 112 healthy reference subjects with bilateral
siteKLG0, 101 had bilateral normal knees based on central radio-
graphic reading (Table I). Of 724 knees with siteKLG2-4, the central
readings reported 93 to be centKLG0, 101 centKLG1 (OARSI JSN
grade0/1 ¼ 61/40), 308 centKLG2 (JSN grade0/1/2 ¼ 98/209/1), 161
centKLG3 (all JSN grade2), and 61 centKLG4 (all JSN grade3).
The rates of OV1 change were of similar magnitude between
healthy reference cohorts deﬁned by site vs central readings and
appeared to increase with greater KLGs (Table I). CentKLG2 knees
with JSN displayed signiﬁcantly (P ¼ 0.03) greater rates of OV1
cartilage thickness change than those without JSN (Table I). Similar
difference in means was found after adjusting for age, sex and BMI
(P ¼ 0.03). In contrast, the OV1 rates of change did not differ
signiﬁcantly between centKLG1 knees with and without JSN
(P ¼ 0.09) (Table I). Similar qualitative observations were made for
total FTJ cartilage thickness change (i.e., the sum of medial and
lateral compartment change), the SRM in centKLG2 knees with JSN
being more negative than in those without JSN, although the dif-
ference did not reach statistical signiﬁcance (P ¼ 0.31 without,
P ¼ 0.43 with adjustment).
Knees with greater medial centJSN grades tended to displayed
greater rates of MFTC cartilage loss (Table II). MFTC cartilage loss in
OARSI medial centJSN grade2 knees was signiﬁcantly (P ¼ 0.02)
greater than that in grade1 knees (Table II), and the conclusion and
Table I
Rates of 1-year change in the femorotibial subregionwith the greatest change in each knee (OV1) and in the total femorotibial joint (FTJ), according to radiographic strata based
on the OAI site and central readings
Site readings Central readings (Boston Univ.)
n OV1 MC
(mm)










Healthy 112 115 [126;105] 9 [17; 35] 0.07 101 111 [122;100] 13 [15; 40] 0.09
KLG0 n.a. e e e 93 120 [132;108] 12 [35; 10] 0.11
KLG1 n.a. e e e 101 138 [156;120] 33 [67; 2] 0.19
KLG1JSN 61 150 [176;125] 55 [101;10] 0.30
KLG1 þJSN 40 119 [143;95] 1 [50;52] 0.01
KLG2 308 136 [148;125] 20 [37;4] 0.14 308 160 [176;145] 40 [59;20] 0.23
KLG2JSN 98 134 [155;115] 25 [54;5] 0.16
KLG2þJSN 210 172 [193;152] 46 [72;21] 0.25
KLG3 299 180 [197;164] 69 [91;47] 0.35 161 203 [225;181] 109 [142;77] 0.52
KLG4 111 201 [222;179] 107 [147;67] 0.50 61 195 [223;166] 84 [137;32] 0.40
CI 95% ¼ [lower bound; upper bound] of the 95 conﬁdence interval. The numbers of site readings (n ¼ 830) and central readings (n ¼ 825) differ, because six cases were not
classiﬁed in our previous paper on the site readings, but were here. In addition we found that from the healthy reference subjects only 101 had bilateral normal knees ac-
cording to the central readings, explaining the total difference of n ¼ 5. Italics indicate that these are subgroups of the KLG1 and KLG2.
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BMI (P¼ 0.02). The observed rate of MFTC change in centJSN grade2
appeared to be similar to that in grade3 knees (P ¼ 0.96) (Table II).
Discussion
This study presents, for the ﬁrst time, rates of cartilage loss in
speciﬁc RKOA strata deﬁned by central OAI readings, namely KLG2
knees with and without radiographic JSN, and knees with medial
OARSI JSN grade2 vs 1. We ﬁnd the maximum subregion change
(OV1) to be greater in centKLG2 knees with than in those without
JSN. Clinical trials that aim at determining risk factors of structural
progression, or the effect of a DMOAD on cartilage loss, should
hence preferably include KLG2 knees with JSN, if signiﬁcantly
cartilage loss (in the placebo group) is to be observed over
acceptable observation periods. The observed rates of MFTC carti-
lage loss in medial grade2 centJSN knees were more than two-fold
greater than in grade1 knees. From a prognostic perspective,
therefore, OARSI JSN grades1 and 2 knees should thus not be
collapsed into the same grade, as done for recruitment purposes by
the OAI site readings. MFTC cartilage loss in medial JSN grade2 and
3 knees, in contrast, were observed to be relatively similar.
It is surprising to what extent the radiographic classiﬁcation
differed between site and central readings, particularly in view of
the site readers having been trained for this purpose. Almost ¼ of
siteKLG 2 knees turned out to not display deﬁnite RKOA in central
readings, and approx. 14% were classiﬁed to not have any radio-
graphic change at all. Enrollment for the OAI extended over a 2-year
period, and this may have involved drift within and between the
site readers. Further, different thresholds were noted between
expert and trained readers for scoring osteophytes and radio-
graphic JSN5.
Radiographic strata other than centKLG2 (and centKLG1) with
and without JSN, and medial centJSN grade2 vs 1, were not
compared statistically, to avoid issues of multiple parallel testing.Table II
Rates of 1-year change in the medial femorotibial compartment (MFTC), according to ra
Site readings
n MFTC MC (mm) CI 95% SRM
Healthy 112 þ2 [10; 20] 0.02
medJSN 0 428 15 [25;5] 0.
medJSN 1 217 43 [60;26] 0.
medJSN 2 (collapsed with gr. 1)
medJSN 3 73 86 [121;51] 0.However, further interesting observations can be made at a
descriptive level: Exclusion of knees from the healthy reference
cohort by central reading did not have a noticeable impact on the
observed rate of cartilage loss. CentKLG0 knees (with risk factors of
RKOA) only had very marginally greater rates of change than
healthy reference knees. The OV1 rate of change in centKLG1 knees
was in between that of centKLG0 and centKLG2, but was almost
identical to that of centKLG2 knees without JSN. Although the
observed rate of change in KLG1 subjects without JSN was greater
than those with JSN, this difference was not statistically signiﬁcant.
The rate and also the SD of change in centKLG2 knees without JSN
was almost identical to that of siteKLG2 knees (who did not have
JSN by deﬁnition); further, removal of KLG0 and 1 knees by the
central readings from the pool of siteKLG2 knees did not appear to
increase the sensitivity to change (SRM). However, centKLG2 knees
with JSN displayed greater sensitivity of femorotibial cartilage loss
(SRM 0.25) than those without JSN (SRM 0.16).
Given that JSN was identiﬁed to be a potent predictor of sub-
sequent cartilage loss10e12, the ﬁnding that centKLG2 knees with
JSN display greater rates of cartilage loss than those without was
not unexpected. A recent clinical trial13 used change in medial
radiographic joint spacewidth (JSW) as an outcome and speciﬁcally
recruited KLG2 knees with JSN. The trial reported a signiﬁcant
reduction in JSW (0.13 ± 0.36 mm) over 1 year in the placebo
group, using a highly controlled (i.e., modiﬁed Lyon Schuss)
radiographic technique13, with the SRM being similar to that
observed for medial compartment cartilage thickness loss in knees
with medial OARSI grade1 JSN in our present study.
In conclusion, presence of radiographic JSN within KLG2 (but
not within KLG1) knees was associated with signiﬁcantly greater
rates of cartilage loss and greater longitudinal sensitivity to change.
Differentiating knees with mild (OARSI grade1) vs moderate
(grade2) medial JSN, and KLG2 knees with and without JSN, is
hence important from a prognostic perspective of predicting
structural progression in KOA. The ﬁndings reported havediographic strata based on the OAI site and central readings
Central readings (BU)
n MFTC MC (mm) CI 95% SRM
101 þ2 [10; 20] 0.02
14 356 14 [30; 1] 0.13
34 209 31 [50;13] 0.25
116 70 [99;41] 0.44
57 43 72 [108;35] 0.59
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efﬁcacy of disease modifying drugs (DMOADs).Contributions
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